World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
69
Citations
14317
World Ranking
2528
National Ranking
1212

Qing Yi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Qing Yi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 240 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Qing Yi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Qing Yi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 69 D-Index — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Qing Yi is affiliated with Houston Methodist in the United States and has contributed extensively to research in medicine, biochemistry, genetics, molecular biology, immunology, and microbiology. Their scholarly output spans key areas including immunology, molecular biology, oncology, hematology, and cancer research.

Their research topics cover a range of subjects such as multiple myeloma research and treatments, CAR-T cell therapy research, immune cell function and interaction, ferroptosis and cancer prognosis, cancer, lipids, and metabolism, immunotherapy and immune responses, and cancer immunotherapy and biomarkers.

Qing Yi has published multiple papers in prominent scientific venues. Notable recent papers include:

  • CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability, 2021, Cell Metabolism
  • Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages, 2020, Cancer Research
  • Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma, 2020, Nature Communications
  • A guideline on the molecular ecosystem regulating ferroptosis, 2024, Nature Cell Biology
  • Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9, 2020, Nature Communications

Frequent publication venues where Qing Yi's work appears include:

  • Blood
  • Cancer Research
  • Nature Communications
  • Cell Metabolism
  • Cancer Cell

Qing Yi has collaborated extensively with other researchers. Frequent co-authors include Jianfei Qian, Liuling Xiao, Qiang Wang, Miao Xian, and Wei Xiong.

Best Publications

  • Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment

    Xingzhe Ma;Enguang Bi;Yong Lu;Pan Su

  • CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability.

    Xingzhe Ma;Liuling Xiao;Lintao Liu;Lingqun Ye

  • Th9 cells promote antitumor immune responses in vivo

    Yong Lu;Sungyoul Hong;Haiyan Li;Jung Sun Park

  • Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma

    De Ke Jiang;Jielin Sun;Guangwen Cao;Yao Liu

  • Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug–induced apoptosis

    Yuhuan Zheng;Zhen Cai;Zhen Cai;Siqing Wang;Xiang Zhang

  • Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function

    Young Hee Lee;Natalia Martin-Orozco;Natalia Martin-Orozco;Peilin Zheng;Jing Li

  • Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004.

    Yuhong Zhou;Yuhong Zhou;Haijun Wang;Wenjing Fang;Jorge E. Romaguer

  • Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells

    Hua Jiang;Wenhao Zhang;Peipei Shang;Hui Zhang

  • Idiotype Immunization Combined With Granulocyte-Macrophage Colony-Stimulating Factor in Myeloma Patients Induced Type I, Major Histocompatibility Complex–Restricted, CD8- and CD4-Specific T-Cell Responses

    Anders Österborg;Qing Yi;Lotta Henriksson;Jan Fagerberg

  • Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice

    Hong Qin;Beatrisa Lerman;Ippei Sakamaki;Guowei Wei

  • Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4 + and CD8 + T cells

    Haiyan Li;Sungyoul Hong;Jianfei Qian;Yuhuan Zheng

  • Cancer and the Microenvironment Myeloma-Osteoclast Interactions as a Model

    Shmuel Yaccoby;Michele J. Wezeman;Aminah Henderson;Michele Cottler-Fox

  • Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma

    Hsiang chi Tseng;Wei Xiong;Wei Xiong;Saiaditya Badeti;Yan Yang

  • Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy

    Yue Jin Wen;Rui Min;Guido Tricot;Bart Barlogie

  • Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo

    Liang Zhang;Zhengzi Qian;Zhengzi Qian;Zhen Cai;Zhen Cai;Luhong Sun

  • Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.

    Yi Hu;Jianhong Lin;Jianhong Lin;Hua Fang;Hua Fang;Jing Fang

  • PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma

    Y. Zheng;J. Yang;Jianfei Qian;P. Qiu

  • Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors

    Yong Lu;Yong Lu;Qiang Wang;Gang Xue;Enguang Bi

  • Cholesterol negatively regulates IL-9–producing CD8+ T cell differentiation and antitumor activity

    Xingzhe Ma;Enguang Bi;Chunjian Huang;Yong Lu

  • Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen.

    Ali Samanci;Qing Yi;Jan Fagerberg;Karin Strigård

  • Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells

    Yue Jin Wen;Bart Barlogie;Qing Yi

  • Human C-Reactive Protein Binds Activating Fcγ Receptors and Protects Myeloma Tumor Cells from Apoptosis

    Jing Yang;Michele Wezeman;Xiang Zhang;Pei Lin

Frequent Co-Authors

Larry W. Kwak
Larry W. Kwak City Of Hope National Medical Center
Anders Österborg
Anders Österborg Karolinska Institute
Håkan Mellstedt
Håkan Mellstedt Karolinska Institute
Bart Barlogie
Bart Barlogie Mount Sinai Hospital
Robert Z. Orlowski
Robert Z. Orlowski The University of Texas MD Anderson Cancer Center
Long Yu
Long Yu Fudan University
Magnus Björkholm
Magnus Björkholm Karolinska University Hospital
Joshua Epstein
Joshua Epstein University of Arkansas for Medical Sciences
Jatin P. Shah
Jatin P. Shah Memorial Sloan Kettering Cancer Center
Mahmood Jeddi-Tehrani
Mahmood Jeddi-Tehrani Avicenna Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, pursuing related fields such as nursing can open diverse career pathways. One popular option is becoming a nurse practitioner, where aspiring professionals can explore some of the easiest nurse practitioner degree programs online. These programs are designed to accommodate students with varying academic backgrounds, making it more accessible to enter healthcare-focused roles.

Specializations like psychiatric mental health nursing are in high demand. The best online pmhnp programs stand out by offering strong clinical placement rates, ensuring graduates gain invaluable hands-on experience. Additionally, those mindful of costs can consider the cheapest pmhnp certificate programs, which provide quality education at a lower price point.

Career prospects for advanced degrees are promising, with salaries varying by location. For example, a doctor of nursing practice salary can be significantly higher in certain states, reflecting regional demand and cost of living. Exploring these online degree options helps immunology enthusiasts broaden their expertise and access impactful healthcare careers.

Best Scientists Citing Qing Yi

Trending Scientists